Analysis suppression from Myristicin

Analysis suppression refers to a substantial decrease in the mind's ability to perform the cognitive operations collectively described as "analysis" — breaking complex information into components, evaluating evidence, identifying logical relationships, detecting errors in reasoning, and synthesizing conclusions. Under normal conditions, these analytical capacities operate largely automatically, allowing a person to assess situations, evaluate claims, and solve problems with relative ease. When analysis is suppressed, this cognitive machinery slows, stalls, or fails entirely, and the person finds themselves unable to engage in even basic forms of structured thinking.

The subjective experience of analysis suppression is one of mental blankness or opacity when confronted with anything requiring thought. A question that would normally be answered automatically requires prolonged, effortful consideration — and even then, the result may be unsatisfying or simply absent. The person may stare at a simple problem and feel that the cognitive tools needed to solve it are simply not available, like reaching for a word that is on the tip of the tongue but will not come. Reading comprehension drops. Arguments cannot be followed. Simple logical deductions feel impossibly complex.

Analysis suppression is mechanistically distinct from sedation (where the person is too drowsy to think),thought deceleration (where thoughts proceed but slowly), andthought disorganization (where thoughts are present but scattered). In pure analysis suppression, the person may be awake, alert, and even have thoughts flowing at normal speed — but the specific capacity for structured evaluation and reasoning has been selectively impaired. In practice, however, analysis suppression frequently co-occurs with these other effects, creating a compound state of cognitive dysfunction.

The effect is most commonly produced by antipsychotic medications (which suppress dopaminergic activity in prefrontal circuits essential for analytical thought), heavy doses ofbenzodiazepines and otherGABAergic depressants,anticholinergic/deliriant substances, heavy doses ofcannabis, and the comedown phase ofstimulants. It can also occur during the peak of high-dosepsychedelic ordissociative experiences, where the analytical mind is temporarily overwhelmed by the intensity of altered perception and emotion. Notably, analysis suppression is one of the primary cognitive effects that makes antipsychotic medications subjectively unpleasant for many patients who take them.

Harm reduction note: Analysis suppression is a clear signal that your cognitive capacity is significantly impaired. During this state, you should avoid making important decisions, engaging in tasks that require careful reasoning (financial transactions, legal agreements, medical decisions), or evaluating the safety of potential actions. If you recognize that your analytical capacity is suppressed, default to conservative choices and defer anything important until the effect has resolved. The impairment is temporary and resolves as the substance wears off or, in the case of chronic medications, as the body adjusts.